Background: Rapid on-site evaluation (ROSE) with cytology preparations plays a critical role in minimally invasive procedures. The time spent by a pathologist performing ROSE is unpredictable and could be used for more cost-effective activities. The solution encountered by several institutions to address this issue is the use of telecytology (TC). This study analyzes the experience of using telecytology for ROSE in a major cancer center over a period of over 2 years.
Methods: A retrospective analysis of all remote TC evaluations for adequacy on fine needle aspiration (FNA) and touch preparations (TP) of core biopsies (CB) performed at a major cancer center was performed. The preliminary adequacy assessment was then compared to the adequacy assessment at final diagnosis.
Results: A total of 12 949 adequacy assessments were analyzed. The most common sites biopsied in our institution were lymph node, lung, and liver. There were 7725 adequacy assessments for CB (59.7%), while adequacy assessment for FNA specimens represented 40.3% (n 5 5224) of the total number of specimens evaluated by ROSE. Perfect concordance between initial adequacy assessment and the adequacy assessment at final cytologic diagnosis was 93% (12 049/12 949). The final diagnosis adequacy upgrade rate was 6.7% (n 5 863), and the adequacy downgrade (a specimen considered adequate on-site that was determined to be nondiagnostic on final examination) was 0.3% (n 5 37).
Conclusions: TC can be easily implemented with the current technologies available. It is costeffective and allows for better patient care with a more efficient use of the pathologist's time and laboratory resources.
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| I N TR ODU C TI ON
The current trend in healthcare relies increasingly on minimally invasive procedures to obtain material for diagnosis, instead of surgical resections. It is in this setting that rapid on-site evaluation (ROSE) with cytology preparations plays an important role. Several authors have shown ROSE to improve patient care by reducing the number of repeat procedures. [1] [2] [3] [4] [5] 
| M A TE RI A L S A ND M E TH ODS
A retrospective analysis of all remote TC evaluations for cellular con- adequacy assessment is considered inadequate but the adequacy assessment at final diagnosis is determined to be diagnostic. An adequacy downgrade occurs when the preliminary adequacy assessment is deemed adequate but the adequacy assessment at final cytologic diagnosis is determined to be nondiagnostic.
| Technical description
The iMedHD2 system by Remote Medical Technologies (RMT; Melville, New York) was used to send the images. The RMT architecture is based on a spoke and hub networked client-server concept. The system is coupled with Optronics® (Goleta, California) or Lumenera® Remote viewing is web-based and uses 1 Gigabit per second intranet connection speeds.
| Process workflow
The CT is informed when a biopsy procedure is about to begin and alerts the cytopathology attending, who proceeds to access the on-site camera through the web browser. The CT prepares slides on-site and selects the appropriate region of interest. She/He then communicates with the attending cytopathologist through a hands-free Vocera TM (San Jose, California) device. ROSE for adequacy is performed with TC assistance. The material was considered adequate if lesional tissue was identified or the radiologic findings were compatible with the radiological and clinical suspicion. Collection of additional material for ancillary studies was obtained if deemed necessary by the pathologist.
| RE S U L TS
A total of 12 949 adequacy assessments were performed during the observed period. The vast majority of procedures were performed in interventional radiology and ultrasound suites. TPs from interventional radiology comprised most of the cytologic evaluations. The most common sites biopsied in our institution were lymph node, lung and liver.
There were 7725 adequacy assessments for CB (59.7%), while The most common cases with discrepancies between the adequacy assessments at initial assessment and final cytologic diagnosis were cases from well differentiated neoplasms from the liver and kidney ( Figure  F2 2) and mesenchymal lesions. Bronchial cells in thick smears also represented challenges in endobronchial ultrasound guided biopsies as they could be mistaken for lymphocytes if present in thick parts of the smears. Apple's FaceTime that has also been evaluated as TC options. 9, 10 Although popular, this application has limitations when used for TC such as quality of the image when changing magnifications and potential network connection issues. Also, the required level of security mandated by most institutions makes it difficult to use such application for clinical purposes. 11 The selection of live image streaming as the platform for TC should be based on the workflow of each individual laboratory and should take in the consideration the resources available, both human and technical, as well as image quality, user-friendliness, reliability, and security of the equipment.
| D I SCUSSION

11
This study represents the largest evaluation of TC to date (n 5 12 949). As a comparison, other larger assessments of digitized scanned slides from other institutions may have a sample size of up to 600 cases. 12 The workflow implemented for this activity was designed to minimize the efforts of the personnel on-site. Communicating with the pathologist and making sure the images transmitted were in focus was the only additional effort required of the on-site personnel. The pathologist would access the images transmitted by the equipment when notified by the personnel on-site. There was no notable increase in time of screening and the feedback from the clinicians was very positive. It allowed direct pathologist to clinician communication, including live discussion of the case. Our study also demonstrated that the use of telecytology did not impact the accuracy of ROSE. The concordance or accuracy in our study was 93%. This was similar to our prior TC studies, suggesting that the learning curve for the implementation of ROSE did not impact accuracy. Also, these results are comparable to previous reports, which have demonstrated an 80% to 95% concordance rate for TC and 66.7% to 97% for conventional on-site methods. [13] [14] [15] [16] [17] [18] [19] A slightly higher concordance obtained from TP might should not be used to report the assistance of a technologist during FNA as 88172 is a physician service code. 32 The CPT code 88333 for the evaluation of TP is a pathology consultation code, although a technical component modifier component can be used. Therefore, the use of telecytology for ROSE is justified both from the point view of an improved patient care as well as from a financial perspective. The investment for the implementation of TC can be recovered through the revenue generated when the pathologist is directly involved in ROSE.
In summary, TC can be easily implemented with the current technologies available. It requires some upfront investment that is offset by additional revenue and time savings obtained from the activity. More importantly, it allows a better patient care throughout the institution with a more efficient and cost effective use of the pathologist time and laboratory resources. The discrepancy rate of adequacy assessment using TC is similar to adequacy assessments performed on-site.
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